As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
the contents by NLM or the National Institutes of Health.
Learn more: PMC Disclaimer | PMC Copyright Notice
Learn more: PMC Disclaimer | PMC Copyright Notice
Virology. 2001 Jan 20; 279(2): 371–374.
Published online 2002 May 25. doi: 10.1006/viro.2000.0757
PMCID: PMC7133764
PMID: 11162792
Coronavirus Spike Proteins in Viral Entry and Pathogenesis
The Full Text of this article is available as a PDF (254K).
References
REFERENCES
1. Baric R.S., Yount B., Hensley L., Peel S.A., Chen W. Episodic evolution mediates interspecies transfer of a murine coronavirus. J. Virol. 1997;71:1946–1955. [PMC free article] [PubMed] [Google Scholar]
2. Dveksler G.S., Pensiero M.N., Dieffenbach C.W., Cardellichio C.B., Basole A.A., Elia P.E., Holmes K.V. Mouse hepatitis virus strain A59 and blocking antireceptor monoclonal antibody bind to the N-terminal domain of cellular receptor. Proc. Natl. Acad. Sci. USA. 1993;90:1716–1720. [PMC free article] [PubMed] [Google Scholar]
3. Fazakerley J.K., Parker S.E., Bloom F., Buchmeier M.J. The V5A13.1 envelope glycoprotein deletion mutant of mouse hepatitis virus type 4 is neuroattenuated by its reduced rate of spread in the central nervous system. Virology. 1992;187:178–188. [PMC free article] [PubMed] [Google Scholar]
4. Gallagher T.M. A role for naturally occurring variation of the murine coronavirus spike protein in stabilizing association with the cellular receptor. J. Virol. 1997;71:3129–3137. [PMC free article] [PubMed] [Google Scholar]
5. Gallagher T.M., Escarmis C., Buchmeier M.J. Alteration of the pH dependence of coronavirus-induced cell fusion: Effect of mutations in the spike glycoprotein. J. Virol. 1991;65:1916–1928. [PMC free article] [PubMed] [Google Scholar]
6. Godfraind C., Havaux N., Holmes K.V., Couteleir J.P. Role of virus receptor-bearing endothelial cells of the blood–brain barrier in preventing the spread of mouse hepatitis virus-A59 into the central nervous system. J. Neurovirol. 1997;3:428–434. [PubMed] [Google Scholar]
7. Holmes K.V., Dveksler G.S. Specificity of coronavirus/receptor interactions. In: Wimmer E., editor. Cell Receptors for Animal Viruses. Cold Spring Harbor Laboratory Press; Cold Spring Harbor: 1994. pp. 403–443. [Google Scholar]
8. Krueger D.K., Kelly S.M., Lewicki D.N., Ruffolo R., Gallagher T.M. Variations in disparate regions of the murine coronavirus spike protein impact the initiation of membrane fusion. J. Virol. 2000 [PMC free article] [PubMed] [Google Scholar]
9. Kubo H., Yamada Y.K., Taguchi F. Localization of neutralizing epitopes and the receptor-binding site within the amino-terminal 330 amino acids of the murine coronavirus spike protein. J. Virol. 1994;68:5403–5410. [PMC free article] [PubMed] [Google Scholar]
10. Kuo L., Godeke G.-J., Raamsman M.J.B., Masters P.S., Rottier P.J.M. Retargeting of coronavirus by substitution of the spike glycoprotein ectodomain: Crossing the host cell species barrier. J. Virol. 2000;74:1393–1406. [PMC free article] [PubMed] [Google Scholar]
11. Luo Z., Weiss S.R. Roles in cell-to-cell fusion of two conserved hydrophobic regions in the murine coronavirus spike protein. Virology. 1998;244:483–494. [PMC free article] [PubMed] [Google Scholar]
12. Pearce B.D., Hobbs M.V., McGraw T.S., Buchmeier M.J. Cytokine induction during T cell mediated clearance of mouse hepatitis virus from neurons in vivo. J. Virol. 1994;68:5483–5495. [PMC free article] [PubMed] [Google Scholar]
13. Perlman S., Lane T.E., Buchmeier M.J. In: Coronaviruses: Hepatitis, Peritonitis and Central Nervous System Disease. Cunningham M.W., Fujinami R.S., editors. Lippincott-Williams and Wilkins; Philadelphia: 2000. pp. 331–348. [Google Scholar]
14. Phillips J.J., Chua M.M., Lavi E., Weiss S.R. Pathogenesis of chimeric MHV-4/MHV-A59 recombinant viruses: The murine coronavirus spike protein is a major determinant of neurovirulence. J. Virol. 1999;73:7752–7760. [PMC free article] [PubMed] [Google Scholar]
15. Rao P.V., Kumari S., Gallagher T.M. Identification of a contiguous 6-residue determinant in the MHV receptor that controls the level of virion binding to cells. Virology. 1997;229:336–348. [PMC free article] [PubMed] [Google Scholar]
16. Saeki K., Ohtsuka N., Taguchi F. Identification of spike protein residues of murine coronavirus responsible for receptor-binding activity by use of soluble receptor-resistant mutants. J. Virol. 1997;71:9024–9031. [PMC free article] [PubMed] [Google Scholar]
17. Sanchez C.M., Izeta A., Sanchez-Morgado J.M., Alonso S., Sola I., Balasch M., Plana-Duran J., Enjuanes L. Targeted recombination demonstrates that the spike gene of transmissible gastroenteritis coronavirus is a determinant of its enteric tropism and virulence. J. Virol. 1999;73:7607–7618. [PMC free article] [PubMed] [Google Scholar]
18. Singh M., Berger B., Kim P.S. LearnCoil-VMF: Computational evidence for coiled-coil-like motifs in many viral membrane fusion proteins. J. Mol. Biol. 1999;290:1031–1041. [PMC free article] [PubMed] [Google Scholar]
19. Skehel J.J., Wiley D.C. Coiled coils in both intracellular vesicle and viral membrane fusion. Cell. 1998;95:871–874. [PubMed] [Google Scholar]
20. Sturman L.S., Ricard C.S., Holmes K.V. Conformational change of the coronavirus peplomer glycoprotein at pH 8.0 and 37°C correlates with virus aggregation and virus-induced cell fusion. J. Virol. 1990;64:3042–3050. [PMC free article] [PubMed] [Google Scholar]
21. Wang F.I., Fleming J.O., Lai M.M.C. Sequence analysis of the spike protein gene of murine coronavirus variants: Study of genetic sites affecting neuropathogenicity. Virology. 1992;186:742–749. [PMC free article] [PubMed] [Google Scholar]
Articles from Virology are provided here courtesy of Elsevier